Patient Files: Familial Chylomicronaemia Syndrome
Dr Karishma Patel talks to PharmaTimes about the challenges of life with this ultra-rare genetic disorder
PharmaTimes Magazine
PharmaTimes is the UK's leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital versions have a total circulation of 23,184, reaching right across the industry into every company and every function. What's more, our circulation includes 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Magazine highlights
View more from the latest edition
On the comms radar
Pharma comms is one of the most dynamic sectors of the industry. So, what should be on communicators’ radar?
The biosimilars era
Biosimilars may have proven their worth, but how can adoption be sped up?
Company focus: Vasopharm
CEO Christian Wandersee explains the hurdles and hopes when developing drugs for traumatic brain injury, a devastating condition for which there is no existing drug treatment
Together as one
We caught up with IQVIA’s SVP global technology solutions, Tal Rosenberg, at the 2018 eyeforpharma Barcelona conference as the company announced the EU launch of its Orchestrated Customer Engagement product, which aims to harmonise pharma's interaction with customers
The ultimate cure?
Gene therapy still needs to overcome some major hurdles to truly fulfil its promise
Is trouble on the horizon for GSK?
Ana Nicholls asks whether GSK’s revenue drop is a short-term blip or a sign of bigger problems
